How much does a box of Copanlisib targeted drug cost?

Copanlisib/Copanlisib (Copanlisib) is a targeted anticancer drug that belongs to a class of drugs called phosphatidylinositol 3 kinase (PI3K) inhibitors. PI3K is a protein kinase involved in regulating cell growth, proliferation and survival, but when overactive, it can promote the growth of cancer cells. Copanliside/Copanisib’s main mechanism of action is to interfere with the proliferation and survival of cancer cells by inhibiting the activity of PI3K.

Copanliside/Kupanisi has just been launched in China and has not been included in medical insurance. The specific price may not be determined yet. Please consult your local pharmacy for details. There is only the American version of the original drug available abroad, and the price is as high as more than 70,000 yuan.

Copanliside/Copanisib has been approved to treat certain types of cancer, especially a malignant lymphoma called follicular lymphoma (Follicular Lymphoma). This drug is usually used in patients who have received other treatments without satisfactory results or who are unable to accept other treatment options. Copanliside/CopanisibUsually given to patients as an injection, treatment can be given intravenously.

Usingcopanliside/copanisib may cause side effects, including low white blood cell count, high blood sugar, high blood pressure, diarrhea, and fatigue. Therefore, doctors regularly monitor patients' blood indicators to ensure that the drug is safe to use.

Overall,Kopanliser/KupanisiIt represents a new generation of treatments that target cancer cell growth and has shown significant efficacy in patients with certain types of cancer. However, patients need to be closely monitored and in close contact with their doctor while using this drug to ensure that the drug's effectiveness is maximized while minimizing possible side effects.